Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens.
Circadian rhythms influence cocaine-seeking behavior in rats, and this behavior may be mediated by variability in the rate of extracellular dopamine clearance across the day:night cycle. We used rotating disk electrode voltammetry to examine dopamine clearance and inhibition of clearance by cocaine in the rat medial prefrontal cortex (mPFC) and nucleus accumbens (NAc). Rats were housed under light:dark conditions (LD, 12 h:12 h) or in constant darkness (DD), the latter given just prior to the day of sacrifice. Tissue was collected at 4-h intervals under LD and DD conditions. Under LD, dopamine clearance in both brain regions was greatest at 4h after lights on. Under DD, there was a blunted but still rhythmic pattern of dopamine clearance across the 24-h cycle. Cocaine-induced inhibition of dopamine clearance in the mPFC was not different across the day:night cycle in rats under LD. Paradoxically, under DD, dopamine clearance in the mPFC was enhanced by cocaine at ZT16, 4 h into the subjective night, and only minimally inhibited at other times. In the NAc, cocaine inhibition of dopamine clearance was lowest at ZT4 under LD, and did not vary under DD. We conclude that dopamine clearance varies both in a diurnal and possibly in a circadian manner in the mPFC, and in a diurnal manner in the NAc. These results indicate that light itself may be used to manipulate molecules implicated in drug addiction.
Sleipness
Evan P
EP
Program in Neuroscience, Washington State University, Pullman, Washington 99164, USA.
Jansen
Heiko T
HT
Schenk
James O
JO
Sorg
Barbara A
BA
D000204:Activity Cycles / Q000502:physiology*; D000818:Animals; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D003042:Cocaine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D003042:Cocaine; D004298:Dopamine
Neuropeptides. 2003 Feb;37(1):57-65
12637037
Neuroendocrinology. 1996 Nov;64(5):337-48
8930934
Neuropsychopharmacology. 1996 May;14(5):325-37
8703301
Prog Drug Res. 2002;59:111-31
12458965
Braz J Med Biol Res. 1997 May;30(5):637-40
9283632
Neurosci Lett. 2003 Jul 31;346(1-2):37-40
12850542
Eur J Neurosci. 2003 Jan;17(2):221-8
12542658
Am J Physiol. 1992 Nov;263(5 Pt 2):R1110-4
1443229
Psychopharmacology (Berl). 2008 Jan;195(4):527-36
17891383
Brain Res. 1981 Oct 26;223(1):205-9
7284805
EMBO Rep. 2007 Apr;8(4):366-71
17347670
Biochem Pharmacol. 2001 Oct 1;62(7):929-32
11543728
Brain Res. 2007 Jan 19;1129(1):34-42
17156761
Psychopharmacology (Berl). 2003 Jul;168(1-2):170-176
12845419
J Neurosci. 2002 Apr 1;22(7):2916-25
11923456
Chronobiol Int. 1998 Sep;15(5):395-423
9787933
Experientia. 1974 Nov 15;30(11):1240-1
4474089
J Neurosci. 2002 Jan 15;22(2):389-95
11784783
BMC Neurosci. 2005 May 02;6:31
15865626
Neuroscience. 2003;119(2):497-505
12770563
Fed Proc. 1983 Aug;42(11):2783-9
6135628
J Biol Rhythms. 2004 Oct;19(5):400-13
15534320
Brain Res. 2005 Dec 14;1065(1-2):132-7
16309631
J Biol Rhythms. 2004 Oct;19(5):361-73
15534317
Neuroscience. 1997 Feb;76(3):737-47
9135047
Physiol Behav. 2005 Oct 15;86(3):347-55
16126238
Mol Cell Endocrinol. 1991 Aug;79(1-3):C153-8
1936532
Physiol Res. 2004;53 Suppl 1:S167-76
15119947
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):9026-30
12084940
J Neurosci. 1995 May;15(5 Pt 2):4102-8
7751968
J Biol Chem. 1994 Mar 11;269(10):7124-30
8125921
Chronobiol Int. 1995 Apr;12(2):87-99
8653803
Psychopharmacology (Berl). 2005 Jan;177(3):315-23
15309375
J Pharmacol Exp Ther. 1995 Jun;273(3):1245-56
7791097
J Neurosci. 2001 Nov 1;21(21):8655-63
11606653
J Pharmacol Exp Ther. 1997 Jun;281(3):1401-7
9190876
Physiol Behav. 2007 Aug 15;91(5):523-30
17573077
J Biol Rhythms. 2001 Aug;16(4):302-11
11506376
Folia Psychiatr Neurol Jpn. 1980;34(4):481-92
7196369
Synapse. 1998 Nov;30(3):334-7
9776137
Brain Res. 1972 Jul 13;42(1):201-6
5047187
Neuroscience. 2006 Jul 7;140(3):753-7
16678973
Nature. 2002 Aug 29;418(6901):935-41
12198538
J Pineal Res. 2004 Apr;36(3):177-85
15009508
Neuroscience. 2000;100(4):741-8
11036208
Neuropsychopharmacology. 2006 Jul;31(7):1452-61
16205775
J Neurochem. 2001 Oct;79(1):130-42
11595765
Science. 1987 Sep 4;237(4819):1219-23
2820058
J Biol Chem. 2003 Jun 13;278(24):22168-74
12682063
J Biol Rhythms. 2005 Oct;20(5):430-40
16267382
Neuropsychopharmacology. 2003 Dec;28(12):2117-23
12865893
Brain Res. 1984 Oct 8;311(1):157-60
6488037
J Neurosci. 2001 Jan 1;21(1):35-44
11150317
Behav Neurosci. 1994 Jun;108(3):624-35
7917055
Gene. 1997 Aug 11;195(1):11-8
9300814
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9377-81
15967985
Pharmacol Biochem Behav. 2004 Sep;79(1):37-42
15388282
Eur J Hum Genet. 2005 Oct;13(10):1101-3
16094306
J Pharmacol Exp Ther. 2000 Jul;294(1):239-47
10871318
Biochem Pharmacol. 1992 May 28;43(10):2189-99
1599505
J Neurochem. 1993 Aug;61(2):637-47
8336146
Brain Res Mol Brain Res. 1998 Jan;53(1-2):277-84
9473694
Mol Pharmacol. 1994 Feb;45(2):312-6
7906856
Arch Gen Psychiatry. 2006 Mar;63(3):324-31
16520439
Am J Psychiatry. 2005 Aug;162(8):1403-13
16055761
Annu Rev Physiol. 2001;63:647-76
11181971
Trends Pharmacol Sci. 1993 Feb;14(2):43-9
8480373
J Neurosci. 2002 Jan 1;22(1):350-6
11756518
J Comp Neurol. 2001 Oct 15;439(2):140-50
11596044
J Biol Chem. 1999 Dec 10;274(50):35794-801
10585462